Bone marrow transplantation from unrelated donors

The Italian experience

E. Lanino, T. Lamparelli, G. Dini, E. P. Alessandrino, F. Aversa, E. Calori, D. Medugno, L. Garbarino, F. Locatelli, P. Marenco, G. Mazzola, F. Porta, N. Sacchi, A. Bacigalupo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We report on 24 patients with leukemia (19 pts), congenital disorders (4 pts) or severe aplastic anemia (1 pt) who received bone marrow transplantation from unrelated volunteer donors in 8 Italian Institutions. All the donor/recipient pairs were serologically HLA-A,B,DR matched; MLR was non reactive in 21 out of 24 cases. Preparative regimens were in accord with standards for diagnosis and disease status and included TBI in 15 patients, busulfan in 8, cyclophosphamide alone in one patient with SAA. GvHD prophylaxis consisted of cyclosporine/methotrexate in the majority of cases; 6 patients received additional immunotherapy with anti-lymphocyte globulin and 1 patient in vivo Campath-1G. The bone marrow was T-cell depleted in 2 cases. Acute GvHD grade II-IV occurred in 87% of patients (gr.III-IV: 57%) and was the main cause of death in 8 cases. Six patients (25%) survive with a median follow-up of g months, (16% actuarial survival at 3 years). A trend in favour of a better outcome has been found for age

Original languageEnglish
Pages (from-to)88-89
Number of pages2
JournalBone Marrow Transplantation
Volume11
Issue numberSUPPL. 1
Publication statusPublished - 1993

Fingerprint

Unrelated Donors
Bone Marrow Transplantation
Busulfan
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HLA-A Antigens
HLA-B Antigens
Aplastic Anemia
Globulins
Methotrexate
Immunotherapy
Cyclophosphamide
Cyclosporine
Cause of Death
Volunteers
Leukemia
Bone Marrow
Tissue Donors
Lymphocytes
T-Lymphocytes
Survival

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Lanino, E., Lamparelli, T., Dini, G., Alessandrino, E. P., Aversa, F., Calori, E., ... Bacigalupo, A. (1993). Bone marrow transplantation from unrelated donors: The Italian experience. Bone Marrow Transplantation, 11(SUPPL. 1), 88-89.

Bone marrow transplantation from unrelated donors : The Italian experience. / Lanino, E.; Lamparelli, T.; Dini, G.; Alessandrino, E. P.; Aversa, F.; Calori, E.; Medugno, D.; Garbarino, L.; Locatelli, F.; Marenco, P.; Mazzola, G.; Porta, F.; Sacchi, N.; Bacigalupo, A.

In: Bone Marrow Transplantation, Vol. 11, No. SUPPL. 1, 1993, p. 88-89.

Research output: Contribution to journalArticle

Lanino, E, Lamparelli, T, Dini, G, Alessandrino, EP, Aversa, F, Calori, E, Medugno, D, Garbarino, L, Locatelli, F, Marenco, P, Mazzola, G, Porta, F, Sacchi, N & Bacigalupo, A 1993, 'Bone marrow transplantation from unrelated donors: The Italian experience', Bone Marrow Transplantation, vol. 11, no. SUPPL. 1, pp. 88-89.
Lanino, E. ; Lamparelli, T. ; Dini, G. ; Alessandrino, E. P. ; Aversa, F. ; Calori, E. ; Medugno, D. ; Garbarino, L. ; Locatelli, F. ; Marenco, P. ; Mazzola, G. ; Porta, F. ; Sacchi, N. ; Bacigalupo, A. / Bone marrow transplantation from unrelated donors : The Italian experience. In: Bone Marrow Transplantation. 1993 ; Vol. 11, No. SUPPL. 1. pp. 88-89.
@article{3f0e61eee9244072b67b0aeb9ca19cb3,
title = "Bone marrow transplantation from unrelated donors: The Italian experience",
abstract = "We report on 24 patients with leukemia (19 pts), congenital disorders (4 pts) or severe aplastic anemia (1 pt) who received bone marrow transplantation from unrelated volunteer donors in 8 Italian Institutions. All the donor/recipient pairs were serologically HLA-A,B,DR matched; MLR was non reactive in 21 out of 24 cases. Preparative regimens were in accord with standards for diagnosis and disease status and included TBI in 15 patients, busulfan in 8, cyclophosphamide alone in one patient with SAA. GvHD prophylaxis consisted of cyclosporine/methotrexate in the majority of cases; 6 patients received additional immunotherapy with anti-lymphocyte globulin and 1 patient in vivo Campath-1G. The bone marrow was T-cell depleted in 2 cases. Acute GvHD grade II-IV occurred in 87{\%} of patients (gr.III-IV: 57{\%}) and was the main cause of death in 8 cases. Six patients (25{\%}) survive with a median follow-up of g months, (16{\%} actuarial survival at 3 years). A trend in favour of a better outcome has been found for age",
author = "E. Lanino and T. Lamparelli and G. Dini and Alessandrino, {E. P.} and F. Aversa and E. Calori and D. Medugno and L. Garbarino and F. Locatelli and P. Marenco and G. Mazzola and F. Porta and N. Sacchi and A. Bacigalupo",
year = "1993",
language = "English",
volume = "11",
pages = "88--89",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Bone marrow transplantation from unrelated donors

T2 - The Italian experience

AU - Lanino, E.

AU - Lamparelli, T.

AU - Dini, G.

AU - Alessandrino, E. P.

AU - Aversa, F.

AU - Calori, E.

AU - Medugno, D.

AU - Garbarino, L.

AU - Locatelli, F.

AU - Marenco, P.

AU - Mazzola, G.

AU - Porta, F.

AU - Sacchi, N.

AU - Bacigalupo, A.

PY - 1993

Y1 - 1993

N2 - We report on 24 patients with leukemia (19 pts), congenital disorders (4 pts) or severe aplastic anemia (1 pt) who received bone marrow transplantation from unrelated volunteer donors in 8 Italian Institutions. All the donor/recipient pairs were serologically HLA-A,B,DR matched; MLR was non reactive in 21 out of 24 cases. Preparative regimens were in accord with standards for diagnosis and disease status and included TBI in 15 patients, busulfan in 8, cyclophosphamide alone in one patient with SAA. GvHD prophylaxis consisted of cyclosporine/methotrexate in the majority of cases; 6 patients received additional immunotherapy with anti-lymphocyte globulin and 1 patient in vivo Campath-1G. The bone marrow was T-cell depleted in 2 cases. Acute GvHD grade II-IV occurred in 87% of patients (gr.III-IV: 57%) and was the main cause of death in 8 cases. Six patients (25%) survive with a median follow-up of g months, (16% actuarial survival at 3 years). A trend in favour of a better outcome has been found for age

AB - We report on 24 patients with leukemia (19 pts), congenital disorders (4 pts) or severe aplastic anemia (1 pt) who received bone marrow transplantation from unrelated volunteer donors in 8 Italian Institutions. All the donor/recipient pairs were serologically HLA-A,B,DR matched; MLR was non reactive in 21 out of 24 cases. Preparative regimens were in accord with standards for diagnosis and disease status and included TBI in 15 patients, busulfan in 8, cyclophosphamide alone in one patient with SAA. GvHD prophylaxis consisted of cyclosporine/methotrexate in the majority of cases; 6 patients received additional immunotherapy with anti-lymphocyte globulin and 1 patient in vivo Campath-1G. The bone marrow was T-cell depleted in 2 cases. Acute GvHD grade II-IV occurred in 87% of patients (gr.III-IV: 57%) and was the main cause of death in 8 cases. Six patients (25%) survive with a median follow-up of g months, (16% actuarial survival at 3 years). A trend in favour of a better outcome has been found for age

UR - http://www.scopus.com/inward/record.url?scp=0027419001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027419001&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 88

EP - 89

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 1

ER -